Optogenetic Seizure Control via Excitatory Neuron Stimulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional optogenetic techniques for treating seizures face challenges in efficiently controlling neural networks due to low expression levels of inhibitory opsins and inefficient ion channel expression, limiting their effectiveness in preventing or halting seizures.

Innovation Solution

An optogenetic system that applies an excitatory stimulus to a population of excitatory neurons, monitored by a sensor and delivered via an optical stimulator, to reduce overall neural activity and prevent or halt seizures, utilizing genetically modified excitatory neurons responsive to optical stimuli, such as Channelrhodopsin 2, and employing a closed-loop feedback system for precise control.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional optogenetic techniques use inhibitory opsins to control neural networks, then seizure control is attempted, but expression levels are low and ion channel efficiency is poor, limiting effectiveness

Engineering Contradiction:
Improveseizure control effectivenessVSAvoidneural activity control efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent inverts the conventional optogenetic approach by using excitatory opsins (Channelrhodopsin-2) on excitatory neurons instead of inhibitory opsins on inhibitory neurons. This inversion leverages the naturally high expression levels and efficient ion channel properties of excitatory neurons to achieve more reliable seizure control. The system monitors local field potentials and applies excitatory optical stimulation to excitatory neurons, which paradoxically reduces overall neural hyperactivity and prevents seizures through closed-loop feedback control.

Inventive Principle:
Principle #13The other way round (Inversion)

2Reliability

If excitatory stimulus is applied to excitatory neurons, then neural activity is reduced and seizures are prevented, but the mechanism counterintuitively increases activity to decrease overall excitability

Engineering Contradiction:
Improveseizure prevention capabilityVSAvoidcontrol system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent implements a closed-loop feedback system that continuously monitors local field potentials (LFP) from neural recordings and dynamically adjusts optical stimulation parameters in real-time. The system detects seizure onset through LFP analysis and applies excitatory optical stimulation only when needed, creating a responsive control mechanism that adapts to changing neural states. This feedback approach enables the counterintuitive strategy of using excitatory stimulation to reduce overall excitability by engaging homeostatic regulatory mechanisms in the neural network.

Inventive Principle:
Principle #23Feedback

3Adaptability or versatility

If conventional methods use inhibitory neurons for optogenetic control, then seizure treatment is attempted, but adaptability and reversibility are limited compared to excitatory neuron approaches

Engineering Contradiction:
Improvetreatment adaptabilityVSAvoidseizure treatment effectiveness
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent inverts the conventional approach by targeting excitatory neurons with excitatory opsins instead of inhibitory neurons with inhibitory opsins. This inversion provides enhanced adaptability because excitatory neurons naturally exhibit higher optogenetic response magnitudes and faster kinetics. The system can be tuned by adjusting stimulation parameters (intensity, duration, frequency) to achieve desired therapeutic effects while maintaining reversibility through closed-loop control that stops stimulation when seizure activity ceases.

Inventive Principle:
Principle #13The other way round (Inversion)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system effectively reduces neural activity, preventing or halting seizures by applying an excitatory optical stimulus to excitatory neurons, offering a more efficient and adaptable approach compared to traditional methods, with the ability to monitor and respond to neural activity in real-time.

Implementation Method 1

Specifically, optogenetic treatments use light to control cells in living tissues which have been genetically modified to respond to light incident upon them. Neurons are modified to create receptors or ion channels which are light-sensitive.

Methodology Applied
Scientific EffectOptogenetics: Photoelectric Effect

Implementation Method 2

utilizing genetically modified excitatory neurons responsive to optical stimuli, such as Channelrhodopsin 2

Methodology Applied
Scientific EffectChannelrhodopsin 2 response: Photoelectric Effect

Data Source

PatentUS11590357B2Optogenetic system and method
Publication Date: 2023.02.28 MINT NEUROTECHNOLOGIES LTD
  • US11590357B2 patent drawing
  • US11590357B2 patent drawing
  • US11590357B2 patent drawing

AI summary

An optogenetic system and method for preventing or halting seizures. The system and method use a sensor for monitoring the activity of a neural network containing a group of target neurons, and generating an input signal indicative of said activity, the target neurons being excitatory neurons. Excitatory stimulation is delivered in the form of an optical signal by an optical stimulator to the target neurons, the optical signal being determined based on the input signal, to reduce the overall activity of the target neurons.